FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to occupational diseases and neurology, and concerns treating a vibration disease. That is ensured by administering octolipen intravenously drop-by-drop in dose of 600 mg day for 10 days in a combination with intramuscular introduction of nicergoline 4 mg 2 times per day for 15 days and physiotherapeutic treatment. Physiotherapeutic treatment involves electrophoresis with 2 % aminophylline on a collar zone for 10–15 minutes in a combination with aeroionotherapy for 15 minutes with course of 10 procedures.
EFFECT: such empirically selected complex of medicinal and physiotherapeutic treatment provides synergetic action of its components, which enables effective treatment of vibration disease caused by both local and general vibration.
1 cl, 6 dwg, 3 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING AND PREVENTING NEUROSENSORY DEAFNESS AND NOISE EFFECTS IN INTERNAL EAR ASSOCIATED WITH IN-PLANT NOISE EXPOSURE | 2014 |
|
RU2554813C1 |
| METHOD OF REHABILITATION OF WORKERS WITH CHRONIC OCCUPATIONAL DISEASES OF RESPIRATORY ORGANS: RHINOPHARYNGITIS, TRACHEOBRONCHITIS CAUSED BY EXPOSURE TO HARMFUL FACTORS OF TITANIUM-MAGNESIUM PRODUCTION | 2019 |
|
RU2716962C1 |
| METHOD OF TREATMENT AND PREVENTION OF RECURRENT BRONCHITIS ASSOCIATED WITH IMPACT OF FINE DUST IN CHILDREN | 2018 |
|
RU2682116C1 |
| METHOD OF TREATING AND PREVENTING CHRONIC INFLAMMATORY DISEASES OF NASOPHARYNX ASSOCIATED WITH INHALATION EXPOSURE TO BENZENE AND FORMALDEHYDE IN CHILDREN | 2016 |
|
RU2618469C1 |
| METHOD OF TREATING AND PREVENTING DYSMETABOLIC NEPHROPATHY IN CHILDREN ASSOCIATED WITH TOXIC ACTION OF CADMIUM, LEAD, CHROME AND PHENOL OF ANTHROPOGENIC ORIGIN | 2015 |
|
RU2598346C1 |
| METHOD FOR PREVENTION AND TREATMENT OF PHYSICAL DEVELOPMENT VIOLATIONS IN CHILDREN ASSOCIATED WITH COMPLEX LOW-LEVEL HABITAT POLLUTION BY LEAD, MANGANESE, NICKEL, CHROMIUM AND CADMIUM | 2017 |
|
RU2639124C1 |
| METHOD OF TREATMENT OF ANEMIC SYNDROME IN CHILDREN ASSOCIATED WITH PERIORAL IMPACT OF MANGANESE AND CHLOROFORM FROM DRINKING WATER | 2017 |
|
RU2662148C1 |
| METHOD FOR DIAGNOSIS OF MYOCARDIUM MORPHOFUNCTIONAL DISTURBANCES FOR CHILDREN OLDER THAN 5 YEARS WITH BRONCHOPULMONARY DISEASES ASSOCIATED WITH EXPOSURE TO BENZENE, TOLUENE, PHENOL AND FORMALDEHYDE | 2016 |
|
RU2612861C1 |
| METHOD FOR TREATMENT AND PREVENTION OF GLOMERULAR AND TUBULOINTERSTITIAL KIDNEY DISEASE IN CHILDREN, ASSOCIATED WITH TOXIC EFFECT OF CADMIUM, LEAD, CHROMIUM AND PHENOL OF TECHNOGENIC ORIGIN | 2015 |
|
RU2580314C1 |
| METHOD OF PREVENTING DEVELOPMENT OF UNCONTROLLED BRONCHIAL ASTHMA FORMS INDUCED BY MANGANESE AND VANADIUM IMPACT IN CHILDREN OVER 5 YEARS OLD | 2014 |
|
RU2555341C1 |
